YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling

ConclusionsBy revealing the existence of a YARS-PI3K-Akt signaling axis in gastric cancer, we discovered that tRNA synthetase YARS is a novel tumorigenic factor, characterized by its upregulation in tumor-derived specimens, as well as its functions in promoting gastric cancer progression.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research